Xylem Inc. $XYL Shares Sold by Mitsubishi UFJ Trust & Banking Corp

Mitsubishi UFJ Trust & Banking Corp lowered its stake in Xylem Inc. (NYSE:XYLFree Report) by 1.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 106,892 shares of the industrial products company’s stock after selling 1,193 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp’s holdings in Xylem were worth $13,828,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Maseco LLP acquired a new stake in shares of Xylem during the 2nd quarter valued at $31,000. ST Germain D J Co. Inc. raised its position in shares of Xylem by 950.0% during the second quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company’s stock worth $33,000 after purchasing an additional 228 shares during the period. Headlands Technologies LLC lifted its holdings in shares of Xylem by 90.6% during the first quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company’s stock valued at $36,000 after purchasing an additional 145 shares during the last quarter. Signature Resources Capital Management LLC acquired a new position in shares of Xylem in the 2nd quarter valued at $39,000. Finally, Zions Bancorporation National Association UT acquired a new position in shares of Xylem in the 1st quarter valued at $40,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on XYL shares. UBS Group upped their price objective on shares of Xylem from $168.00 to $175.00 and gave the company a “buy” rating in a research note on Thursday, November 6th. Weiss Ratings restated a “buy (b-)” rating on shares of Xylem in a report on Thursday. Robert W. Baird set a $178.00 price objective on shares of Xylem in a research note on Wednesday, October 29th. Royal Bank Of Canada boosted their target price on shares of Xylem from $169.00 to $176.00 and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Finally, Cowen reaffirmed a “hold” rating on shares of Xylem in a research report on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $166.90.

View Our Latest Research Report on Xylem

Xylem Stock Down 3.2%

XYL stock opened at $142.58 on Friday. The company has a 50 day moving average of $146.17 and a two-hundred day moving average of $136.91. The company has a market cap of $34.71 billion, a price-to-earnings ratio of 36.65, a PEG ratio of 2.50 and a beta of 1.15. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $154.27. The company has a quick ratio of 1.43, a current ratio of 1.96 and a debt-to-equity ratio of 0.17.

Xylem (NYSE:XYLGet Free Report) last posted its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 EPS for the quarter, beating the consensus estimate of $1.23 by $0.14. The business had revenue of $2.27 billion for the quarter, compared to analysts’ expectations of $2.22 billion. Xylem had a net margin of 10.66% and a return on equity of 10.77%. Xylem’s revenue was up 7.8% on a year-over-year basis. During the same period in the previous year, the company posted $1.11 EPS. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, equities analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Insider Transactions at Xylem

In other news, Director Victoria D. Harker sold 1,700 shares of the firm’s stock in a transaction dated Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the sale, the director directly owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This trade represents a 9.15% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the transaction, the chief accounting officer owned 2,957 shares in the company, valued at $413,861.72. This represents a 25.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 13,121 shares of company stock valued at $1,982,459 in the last three months. Corporate insiders own 0.27% of the company’s stock.

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

See Also

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.